rs774556951
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001039141.3(TRIOBP):c.5185-12C>A variant causes a intron change. The variant allele was found at a frequency of 0.000000707 in 1,414,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )
Consequence
TRIOBP
NM_001039141.3 intron
NM_001039141.3 intron
Scores
2
Splicing: ADA: 0.9528
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 3.88
Publications
0 publications found
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
- autosomal recessive nonsyndromic hearing loss 28Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.2).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 7.07e-7 AC: 1AN: 1414738Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 698980 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
1414738
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
698980
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32844
American (AMR)
AF:
AC:
0
AN:
36606
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25260
East Asian (EAS)
AF:
AC:
0
AN:
37836
South Asian (SAS)
AF:
AC:
0
AN:
80296
European-Finnish (FIN)
AF:
AC:
0
AN:
50036
Middle Eastern (MID)
AF:
AC:
0
AN:
5678
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1087516
Other (OTH)
AF:
AC:
0
AN:
58666
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.